{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:32:38Z","timestamp":1792096358438,"version":"4.4.0"},"reference-count":25,"publisher":"Informa Healthcare","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1185\/030079904125004330","type":"journal-article","created":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T21:10:56Z","timestamp":1138828256000},"page":"1227-1233","source":"Crossref","is-referenced-by-count":32,"title":["Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model"],"prefix":"10.1185","volume":"20","author":[{"given":"Bobby Q.","family":"Lanier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Finegold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"D\u2019Arienzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Granet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur B.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg L.","family":"Ledgerwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2008,8,29]]},"reference":[{"key":"CIT0001","first-page":"1","volume":"21","author":"Weeks ER","year":"1987","journal-title":"Monogr Allergy"},{"key":"CIT0002","first-page":"95","volume":"70","author":"Abelson MB","year":"1993","journal-title":"Differential diagnosis of ocular disorders. Ann Allergy"},{"issue":"3","key":"CIT0003","first-page":"127","volume":"1","author":"Abelson MB","year":"2003","journal-title":"Ocular allergic disease: mechanisms, disease sub-types, treatment. The Ocular Surface"},{"key":"CIT0004","first-page":"p. 50","author":"Abelson MB","year":"2000","journal-title":"Allergic diseases of the eye. Philadelphia: W.B. Saunders"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1981.03930010304018"},{"key":"CIT0006","first-page":"57","volume":"27","author":"Woodward DF","year":"1986","journal-title":"Nieves AL. Conjunctival immediate hypersensitivity: re-evaluation of histamine involvement in the vasopermeability response. Invest Ophthalmol Vis Sci"},{"key":"CIT0007","first-page":"39","volume":"42","author":"New drugs for allergic conjunctivitis","year":"2000","journal-title":"Med Lett Drugs Ther"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.2000.078s230052.x"},{"key":"CIT0009","first-page":"1252","volume":"278","author":"Sharif NA","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1996.12.389"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.1999.tb01171.x"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.88.379"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80315-6"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62814-1"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(98)00044-0"},{"key":"CIT0019","first-page":"1462","volume":"22","author":"Butrus S","year":"2000","journal-title":"1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model. Clin Ther"},{"key":"CIT0020","first-page":"60","volume":"230","author":"Abelson MB","year":"2000","journal-title":"1%) compared to Claritin (loratadine 10 mg) tablets in acute allergic conjunctivitis in the conjunctival allergen challenge model. Acta Ophthalmol Scand Suppl"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.117.5.643"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2000.36.11.1136048"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)90004-5"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)80027-3"},{"issue":"1","key":"CIT0030","first-page":"84","volume":"108","author":"Abelson MB","year":"1990","journal-title":"Conjunctival allergen challenge: a clinical approach to studying allergic conjunctivitis. Arch Ophthalmol"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.1999.tb01172.x"},{"issue":"1","key":"CIT0032","first-page":"29","volume":"26","author":"Whitcup SM","year":"2004","journal-title":"Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis. Clin Ther"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1076\/ocii.11.4.247.18261"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079904125004330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T08:42:02Z","timestamp":1481618522000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079904125004330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2004,6,11]]},"published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1185\/030079904125004330"],"URL":"https:\/\/doi.org\/10.1185\/030079904125004330","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}